Ads
Ads
Federal prosecutors have said that Insys, based in Arizona, embarked on an intensive marketing plan — including paying doctors for sham educational talks and luring others with lap dances — to sell its under-the-tongue fentanyl spray, Subsys, which was federally approved to treat patients with cancer. Meanwhile, McKesson has reached a settlement with its investors over allegations it missed suspicious opioid shipments. Syndicated from https://khn.org/morning-breakout/insys-founder-sentenced-to-5-5-years-in-prison-for-scheme-that-involved-bribing-doctors-to-prescribe-opioids/
Ads